brokers call

Broker's Calls

UOBKH calls Centurion Corp a stock for ‘growth-minded investors’

Analyst Adrian Loh has kept his “buy” call with a higher target price of $1.11, from 85 cents previously.

Broker's Calls

Macquarie revises Singapore earnings growth for FY2024 to 7% from 3%

Macquarie’s base case for Singapore is a further 7% EPS growth for 2025E.
OCBC downgrades to ‘hold’ on PropNex, while upgrading TP to 96 cents - THE EDGE SINGAPORE

Broker's Calls

OCBC downgrades PropNex to 'hold' but raises target price to 96 cents

This comes following the surge in new private home sales in October.

Broker's Calls

Yoma Strategic faces currency and other challenges: PhillipCapital

In its 1HFY2025 results, Yoma Strategic announced that revenue had declined 15% y-o-y to US$111.6 million.

Broker's Calls

Morningstar pushes back Nio’s breakeven timeline, reduces fair value estimate following 3QFY2024 earnings release

Morningstar analyst Vincent Sun maintains a “four star” rating on Nio.

Broker's Calls

OCBC maintains ‘buy’ on Keppel Infrastructure Trust; fair value estimate unchanged

This comes following KIT’s proposed acquisition of a 50% equity interest in Keppel Marina East Desalination Plant.

Broker's Calls

CGSI and Maybank maintain ‘buy’ on Sembcorp; TP unchanged following the divestment of Sembcorp Environment

CGSI has kept its target price unchanged at $7.32 while Maybank Securities has maintained its target price at $6.

Broker's Calls

CGS International upgrades Riverstone Holdings to ‘add’ as it sees better prospects in FY2025

Analyst Ong Khang Chuen increased his target price to $1.10 from 95 cents previously after Riverstone’s 3QFY2024 results.

Broker's Calls

Analysts generally positive on OCBC following 3QFY2024 earnings, with most raising their TPs

UOB Kay Hian, Maybank Securities, PhillipCapital, CGSI and Goldman Sachs have maintained their “buy” calls on OCBC.

Broker's Calls

HSBC, UOBKH, Maybank, RHB, CGSI and Citi maintain ‘buy’ on Singtel following its 1HFY2025 results

HSBC, CGSI and UOBKH have kept their target price unchanged at $3.65, $3.70 and $3.58, respectively.
×